Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777539
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-19
First Post:
2021-02-23
Brief Title:
Comparing the Safety and Benefit of Natalizumab Tysabri At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
Sponsor:
Organization:
Nantes University Hospital